Arved G Deecke, Founder of BENEBION, added: “We have been exploring the Rhodotron® as a potential solution for a long time, and we are thrilled to finally align with market conditions to make this project a reality. We look forward to collaborating with IBA’s world-leading experts to meet the rapidly growing market demand for our services in the region. This solution promises to meet our expectations in terms of efficiency, productivity, and capacity while enhancing the quality of service our customers appreciate through our just-in-time approach.”
About IBA
Ad Statistics
Times Displayed: 19605
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
Back to HCB News
